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ryptosporidiosis is an emerging food and water borne zoonotic disease, which is caused by genus 
Cryptosporidium. The first Cryptosporidium spp. was isolated from mice in 1907 and gained 
importance when it was found in an HIV positive patient. It usually causes self-limiting diarrhea 
in young children and immunocompetent patients. However, it may lead to chronic diarrhea with life 
threatening condition in immunocompromised patients. Other complications related to this transmittable 
infection may include respiratory problems, skin rashes and headache. HIV/AIDS patients are highly 
susceptible host for this parasite. Cryptosporidium parvum and Cryptosporidium hominis are the known 
pathogenic species, prevalent among humans and they are being transmitted through contaminated food 
and water. Usually, the diagnosis of Cryptosporidium spp. is dependent on microscopic technique in 
many countries, which has a low sensitivity and specificity leading to false positive results. However, for a 
step forward to successful epidemiological studies, advanced techniques (Serological and DNA-based) 
provide us the better ways of diagnosis with more sensitivity and specificity. Furthermore, no antiparasitic 
drug has found to be effective against Cryptosporidium spp. except Nitazoxanide which is FDA-approved 
and effective only when administered along with antiretroviral therapy. In this regard, present review 
summarizes the various epidemiological studies conducted around the globe along with modern 
diagnostic tools and the suitable treatment available now a days. This systemized review will help the 
scientists to better understand all the aspects of cryptosporidiosis at one platform which may help in 
designing surveillance studies through selection of sensitive diagnostic techniques. The new drugs 
mentioned in this review may also help to better control this parasite in humans, especially 
immunocompromised individuals.
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Introduction  
Cryptosporidium spp., an opportunistic intracellular 
protozoan parasite, belong to Phylum Apicomplexa and 
causes high economic losses in case of morbidity and 
mortality by affecting the gastrointestinal tract of sheep, 
goat, pig, cattle and human [1]. The first specie was 
isolated from gastric juice of mice, named as 
Cryptosporidium muris, in 1907 by Tyzzer [2]. Later, 
Cryptosporidium was also detected, from human stool 
sample in 1976 and became most emergent protozoa 
due to its zoonotic importance. Despite, 
Cryptosporidium spp. are host specific, there are 26 
recognized species causing chronic diarrhea, dysentery 
and malabsorption in humans as well as in farm animals. 
Most prevalent species in humans are C. parvum and C. 
hominis. However, new species or new strains are going 
to be discovered due to rapid genetic recombination as 
i) two or more species are affecting the same host at the 
same time ii) it undergoes both sexual and asexual 
production leading to genetic variation [3]. 
Chances of infection; chronic diarrhea/dysentery, are 
more in immunocompromised patients like HIV 
patients as compared to Immunocompetent patients; 
who suffer with a short-term and self-limiting diarrhea 
[4,5]. In the past, Cryptosporidium was considered to be 
linked with childhood diarrhea, malnutrition. Situation 
became worse in 1993 when 4 million people got 
Cryptosporidium infection in USA and Milwaukee. 
Despite of the evidence, cryptosporidiosis was under-
diagnosed, and the treatment was only symptomatic [6].  
Nevertheless, new diagnostic tools and literature has 
improved the estimate of global burden. However, there 
are still gaps which need to be filled, particularly in the 
fields of epidemiological studies, diagnosis and proper 
cure for cryptosporidiosis. Moreover, there is a 
deficiency of well-organized and comprehensive reviews 
covering all the aspects of cryptosporidiosis i.e. disease 
outbreaks, modern diagnostic tools and therapeutic 
controls especially in HIV patients. Such detailed 
reviews are very important for the young parasitologists 
and researchers for better understanding the current 
scenarios regarding the disease epidemics, modern 
diagnostic tools and the latest drug discoveries.  
Considering all the above-mentioned prospects, 
following review was planned to summarize a detailed 
information about the disease burden of 
Cryptosporidium infection in many countries, modern 
diagnostic tools and the new drugs available against 
Cryptosporidiosis.  
Methods 
Literature Search Strategy and Selection Criteria 
The main objective of writing this review was to 
summarize recent advancements in some aspects of 
cryptosporidiosis important for controlling the disease, 
including epidemiology and recent disease outbreaks in 
various countries, virulent factors, latest diagnostic 
techniques and recently available drugs to cure 
Cryptosporidium infection, particularly in HIV/AIDS 
patients. Doing so, a massive search was carried out on 
google scholar by providing different terms like 
“Cryptosporidiosis”, “Disease outbreaks of 
Cryptosporidium parvum”, “Epidemiological studies on 
Cryptosporidium parvum”, “Cryptosporidium infection 
is HIV/AIDS patients”, “Cryptosporidium infection in 
children”, “diagnostic techniques in Cryptosporidium 
infection”, “modern techniques for the identification of 
Cryptosporidium parvum”, “DNA based techniques for 
the identification of Cryptosporidium in humans”, 
“Mortality rate in immunocompromised patients due to 
Cryptosporidium spp.”, “how to treat Cryptosporidium 
infection in humans”, “latest drug discoveries against 
Cryptosporidium infection”, “FDA approved drugs for 
cryptosporidiosis”.  A total of 65 citations were reviewed 
after screening according to the contents of this review. 
Discussion  
Epidemiology 
Early epidemiological studies have revealed the 
prevalence of Cryptosporidium to be 1% in developed 
countries while 5-10% in poor countries [6]. However, 
results of recent studies, based on serological and 
molecular techniques, revealed that the previous studies 
have underestimated the frequency of C. parvum 
infection indicating the prevalence rate of 15-25% in 
diarrheal patients [6]. 
Disease burden 
Numerous researches have been conducted on 
Cryptosporidiosis throughout the world due to its 
zoonotic and opportunistic behavior. Regarding the 
global disease burden published in 2010, highest 
prevalence rate of 3.5-35.8% has been documented in 
America, followed in order by Africa (2.6-21.3%), 
Europe (0.1-14.4%) and Asia (1.3-13.1%) [7]. However, 
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a brief history of current occurrence of cryptosporidiosis 
documented in various hosts along with various 
diagnostic techniques is listed in Table 1. 
Transmission and Pathogenesis 
C. parvum mostly transmit either by direct or indirect 
ways. Direct transmission occurs when humans drink 
contaminated water or food with infected fecal material 
or by direct touching the infected person. Chances of 
disease spread are higher in day care centers and schools, 
where children get exposed to the contaminated surface 
and mud while playing. Meanwhile, a person can also 
get infection with sexual practices. Moreover, indirect 
transmission may also occur by drinking or eating 
contaminated water and food, respectively. It is clear 
with evidence that C. parvum can easily be passed 
through water filtrations plants due to its very small size 
of one micron. Furthermore, there is no effect of 
chlorination on these parasites during water treatment. 
So, drinking water is a main source of its transmission 
[13,41,42]. 
Pathologically, Cryptosporidium cause 
inflammatory damage to the epithelium of small 
intestine, which leads to the malabsorption and 
increased intestinal secretions resulting in diarrhea, 
dysentery, vomiting and nausea which may last for more 
than seven days. Situation may lead to death due to sever 
and persistent diarrhea in very young children and 
immunocompromised/HIV patients. By entering the 
host, they attach with intestinal epithelium with the help 
of gp900 and gp60 (glycoproteins) and start 
proliferating with the help of micronemes and rhoptries, 
resulting in the formation of parasitophorous vacuoles 
where they undergo sexual and asexual reproduction. 
The whole situation is called cryptosporidiosis [42]. 
Some studies have shown that Cryptosporidium may 
also affect the respiratory tract and cause some 
respiratory disorders along with skin rashes and 
headache [4,7,43]. Several virulenec factors cause 
damage to the host cells are mentioned in Table 2 [1]. 
Associated risk factors 
It is evident from various studies that many associated 
risk factors may likely to be linked with occurrence of 
cryptosporidiosis in humans. Some of them found 
associated with varied prevalence of cryptosporidiosis 
have been listed below: 
Seasonal variations 
Cryptosporidiosis has been found endemic throughout 
the year in various parts of the world, but infection is 
most likely to be happened in rainy season due to water 
contamination [44]. In a critical study, another aspect 
was highlighted when Cryptosporidium along with 
Giardia and Entamoeba showed clear seasonal variation. 
The prevalence was stable before rainy season but 
during the rainy season, an increased rate of infection 
was noticed. However, this analysis does not support the 
pattern in case of cattle host. 
Age 
As a result of cryptosporidiosis, different immune 
responses can be observed which are dependent on age 
variation of host. Cryptosporidiosis is found to be more 
prevalent in children of age less than 24 months as they 
have less developed immune system as compared to 
adults [11]. Some supporting results were obtained in a 
research conducted at a goat farm in Brazil. This study 
showed more prevalence of Cryptosporidium in juvenile 
(age less than 12 months) as compared to adults (age 
more than 12 months) as all 4.8% prevalence was 
observed in juvenile animals [45]. To observe the 
prevalence of cryptosporidiosis, a farm level study was 
performed which revealed the risk to be high in calves of 
age 8-21 weeks in comparison with 0-7 days aged calves. 
During the same year, similar results were found in 
buffalo calves which showed high risk of prevalence of 
infection in calves of age 1-15 days [46]. In another farm 
level study, PCR study disclosed cryptosporidiosis to be 
more prevalent in pre-weaned calves as compared to 
post weaned calves. In human, Cryptosporidium was 
comparatively more prevalent in children of age 7-15 
days than children of 3-12 years. 
Gender 
Occurrence of cryptosporidiosis is higher in male 
population as compared to female population. However, 
it may vary due to the exposure level of males and 
females. In china, It has been observed that the 
prevalence of Cryptosporidium infection was 3 times 
higher in males (12.6%) as compared to those of females 
(4.4%) [47]. 
Socio-economics behavior 
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Socio-economic behavior of host directly affects the 
transmission of Cryptosporidium. Cryptosporidium is 
transmitted through ingestion of parasites which could 
be by means of waterborne, person to person and food 
borne whereas the middle one is occasional. The 
cryptosporidium mostly affects children with 
immunosuppression while suppression is more 
prominent in malnourished children as compared to 
children aged less than 6 months which are breastfed 
[48]. In a study, it was observed that cryptosporidium 
spp., were more prevalent in rural areas especially in the 
persons exposed to public toilets and infected with HIV 
[49]. In another investigation, samples from 1731 drug 
abuser rehabilitation patients were collected to record 
prevalence of Cryptosporidium spp., infection and the 
results showed 19.6% persons to be positive with 
infection. 
Diagnostic Tools 
 Conventional Method 
Traditionally, Cryptosporidium oocysts detection in 
environment, food, water, tissue and fecal sample has 
greatly relied on microscopic examination. But when it 
comes to the identification of Cryptosporidium, 
morphological characters are few. Therefore, 
identification based on light microscopy is time 
consuming and unreliable. Several staining techniques 
are used to identify Cryptosporidium oocysts. The least 
simple stains include modified Ziehl–Neelsen, Kinyoun, 
dimethyl sulphoxide carbol fuchsin and safranin–
methylene blue. However, samples containing less 
oocysts number can suffer low sensitivity and/or 
specificity. Moreover, negative staining methods are also 
available. For example, by using chemicals like 
malachite green and green perbromide, background of 
slide is stained leaving the oocysts unstained. These 
latter staining techniques are time consuming, laborious 
and require perfection. Moreover, none of the 
techniques is helpful to identify Cryptosporidium 
species. For the identification of Cryptosporidium 
oocysts, modified Ziehl-Neelsen staining and wet mount 
preparation methods are also commonly used [36]. 
Another method for the identification and detection of 
Cryptosporidium oocysts is flow cytometry. To identify 
Cryptosporidium in sewage samples and water, Vesey 
used a skytron Argos 100-5 instrument spiked with 
oocysts stained with an FITC-C-mAb. The outcome of 
this study is encouraging by means of flow cytometry 
because it detects as few as 1000 oocysts/L.  
 Immunological Assays 
For detection and identification, Immunological 
methods have several advantages over microscopic 
techniques. For instance, direct fluorescent antibody 
(DFA) and fluorescence microscopy assay use 
fluorescence in isothiocyanate-conjugated anti-
Cryptosporidium monoclonal antibody (FITC-C-
mAb), which identify epitopes on the surface of 
Cryptosporidium oocysts with high sensitivity (98.5–
100%) and specificity (96–100%) for Cryptosporidium 
oocysts detection in environmental samples and fecal 
smears. FITC-C, commercially available monoclonal 
antibody, is used for enumerating and detecting 
Cryptosporidium oocysts routinely in environmental 
and fecal samples. DFA assays which are based on 
monoclonal antibody can differ in their sensitivity and 
specificity of diagnosis which depends on many factors 
including ‘biophysics’ detection system, antibody 
conjugated reporter (enzyme fluorochrome), 
Cryptosporidium antigen used to develop mAb and the 
avidity and subclass/class of the antibody. IgG 
monoclonal antibody seems to have better avidity to 
Cryptosporidium oocyst surface antigens as compared 
to IgM resulting in better recoveries with immuno-
magnetic separation (IMS) within water samples of high 
turbidity. Both molecular interaction and fluorochrome 
selection are the critical aspects and are responsible for 
false positive results due to autofluorescence in emission 
and excitation spectra. Though different monoclonal 
antibodies have been developed but commercially 
existing mAbs cannot identify Cryptosporidium 
specifically. Monoclonal antibodies have been 
developed with lesser number of Cryptosporidium 
parvum oocysts [50]. 
In the last few years, identification and diagnostic 
trends have been greatly changed towards EIA (Enzyme 
immunoassays), IC (Immuno-chromography) and 
ELISA (Enzyme Linked Immunosorbent Assay) for the 
detection of Cryptosporidium oocyst antigens. 
Specificity of these assays is reported to be high (98–
100%). Advantage of these assays is that they detect 
infections when oocysts are not being excreted in feces 
[51]. while limitation of some kits may be seen because 
they mainly depend upon visual inspection which 
enable subjective interpretation of test results.  
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Region Animal 
species 
Technique used 
for detection 
Total samples Positive 
samples 
Prevalence (%) Reference 
Africa 
Nigeria Human PCR 500 222 44.4 [8] 
Egypt Human Microscopy 1275 214 17 [9] 
Kenya Human Microscopy 541 187 34.5 [10] 
Human ELISA 1778 196 11 [11] 
Zambia Sheep & Goat ELISA 250 107 42.8 [12] 
Ghana Human Microscopy 320 63 19.7 [13] 
Europe 
Brazil Horse Microscopy 71 25 35.21 [14] 
Canada Human PCR 108 17 15.7 [15] 
Jamaica Human PCR 35 25 71.45 [16] 
Mexico Sheep Microscopy 37 12.8 34.3 [17] 
Italy Dogs Microscopy 140 5 3.5 [18] 
Spain Sheep Microscopy 583 344 59 [19] 
New Zealand Cattle Microscopy 554 109 19.7 [20] 
Possum Microscopy 39 5 12.8 [21] 
Rats Microscopy 25 5 20 
Cattle Microscopy 1190 31 2.6 [22] 
USA 
California Pig Microscopy 221 12 5.4 [23] 
Colorado Dog PCR 129 9 7 [24] 
Texas Human ELISA 196 279 70.2 [25] 
Southeastern USA Deer Microscopy 360 32 8.8 [26] 
Asia 
Bangladesh Human PCR 3646 1349 37 [27] 
 Human qPCR, ELISA 
Quick Check,  
832 145 17.4 [5] 
India Bovine Microscopy 455 26 5.71 [28] 
Buffalo Microscopy 162 62 38.3 [29] 
Human Microscopy, 
ELISA 
637 97 15.23 [30] 
Iraq Human Microscopy 600 203 19.17 [31] 
Equines Microscopy 107 29 27.10 [32] 
Jammu and Kashmir Sheep Microscopy 120 88 73.33 [33] 
Nepal Human Microscopy 75 8 10.6 [34] 
Pakistan (Lahore) Cattle Microscopy 250 68 27.2 [35] 
East west Pakistan Human Microscopy 200 18 9 [36] 
Thailand Mussels Microscopy 56 7 12.5 [37] 
Australia 
New South Wales Human PCR 261 154 59 [38] 
Sydney Kangaroo Microscopy 3557 239 6.5 [39] 
Western Australia Pig Microscopy 646 39 6.03 [40] 
Table 1: Worldwide Prevalence (%) of Cryptosporidium spp. with respect to diagnostic tools. 
Virulence factors Functions 
Aminopeptidase, Serine proteases Excystation 
Glycoprotein; gp900, gp60, P30, Cp47, TRAP-C1, CpMIC1, P23 Adhesion, Invasion 
Hemolysin H4 Membrane lysis 
CpABC Nutrient transport 
CpATPase2 Biomembrane heavy metal transport 
CpATPase3 Ion or phospholipid transport 
HSP70/90 Stress protection 
Cysteine protease Cytokine modulation 
Acetyl CoA synthetase Fatty acid metabolism 
Table 2: Some virulence factors of Cryptosporidium spp. 
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Furthermore, these assays like many other 
immunological approaches do not diagnose 
Cryptosporidium genotype or species. So far, no such 
immunological tool is present which makes a distinction 
among oocysts of dissimilar species. One effort has been 
made with the development of PCR-EIA which 
differentiates between C. hominis and C. parvum. In a 
recent study, results have shown the 100% specificity 
and 86.6% sensitivity of antigen ELISA for 
Cryptosporidium [52]. 
 DNA Based Approaches 
Molecular techniques are available to find out species, 
genotypes and sub-genotypes of Cryptosporidium to 
differentiate among human and animal pathogens. 
Nucleic acid-based methods have been evaluated for 
species identification in animals and human from 
environmental, water and fecal samples. Some methods 
are based on in-situ hybridization of probes within 
oocysts to specific genetic loci, while most methods are 
based on specific amplification of loci from genomic 
DNA by PCR. These applications have led to 
understanding Cryptosporidium species regarding 
biology, ecology, epidemiology, systematic and 
population genetics for control and prevention of 
cryptosporidiosis in animals and humans. DNA profiles 
from human isolates showed two different genotypes, C. 
hominis (anthroponotic) and C. parvum zoonotic 
genotype. Analysis of tri-nucleotide sequence has shown 
twelve subtypes of Cryptosporidium hominis and seven 
subtypes of Cryptosporidium parvum [53]. 
FISH (Fluorescent In-situ Hybridization) utilizes 
probes (fluorescently-labelled oligonucleotides) by 
targeting RNA or DNA sequences. For identification of 
Cryptosporidium, most of FISH assays are employed on 
RNA hybridization rather DNA by making target on a 
small subunit of nuclear rRNA of variable region 
[50,54]. Because within cell, small subunit (SSU) has a 
high copy number considered as rich target. Some 
limitations with the use of FISH probes depend upon the 
viability of oocysts as SSU-rRNA decay during cell death 
making useless the FISH technique. Degradation varies 
with environmental conditions including RNase 
contamination, pH, salinity and temperature etc. 
 Advanced molecular assays 
Different methods are available regarding PCR and 
many of them have been applied to Cryptosporidium in 
the past. A variety of techniques have been evaluated, 
but currently, only those methods are needed which are 
easy to perform, universally applicable and effective in 
approach.  
 Fingerprinting 
Different techniques are available which permit genetic 
fingerprint to be developed for parasite sample. Such 
techniques based on genome(s) screening for distinction 
in organization and sequence. Positive approach of 
some methods is that no earlier genomic information is 
needed for a sample which is to be characterized. 
However, the disadvantage is that pooled organism’s 
genetic fingerprinting show organism’s population 
rather than individual, therefore, individual markers 
may not signify all population. However, these 
techniques have valuable applications. RAPD (Random 
Amplification of Polymorphic DNA) or AP-PCR 
(Arbitrarily Primed-Polymerase Chain Reaction) are 
developed, based on DNA fragments amplification 
usually using single primers (10-mer) following 
separation of amplicons by polyacrylamide or agarose 
gel electrophoresis. This technique has the benefit of 
being easy, fast and efficient. Band profiles 
reproducibility can be raised by using dissimilar thermal 
cyclers, primer sensitivity, DNA quality and template 
concentration.  
 AFLP (Amplified fragment length 
polymorphism) 
AFLP has been used in parentage analysis, forensic 
science, for genetic investigation and disease diagnosis 
in humans and animals. This technique is based on (i) 
DNA digestion with two restriction enzymes (ii) ligation 
to 5′ and 3′- end with specific adapters of restriction 
fragments (iii) use of primers for amplifying restriction 
fragments (iv) analysis of subsequent restriction 
fragments through electrophoresis. AFLP has the 
advantage of being used to composite DNA of every 
origin. PCR can be applied with high stringency that can 
attained high discrimination level. Disadvantage of this 
technique is that it takes more time than other 
fingerprinting methods. Occasionally, in band profiles a 
high variability can limit the AFLP performance, but this 
technique has been utilized to find out the genotype of 
different organisms, including protozoa but has not 
been utilized to Cryptosporidium [55]. Some 
researchers have focused on satellite DNA utilization for 
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genetic make-up analysis of parasite populations. 
Microsatellites and Minisatellites have been used as 
ubiquitous and profuse in all eukaryotic genomes. They 
are usually non-transcribed and sustain polymorphism 
because of alteration in repeat number. On gel 
electrophoresis, this change let the alleles to be scored by 
size and characterization is done by variability in alleles. 
Thus, it is utilized to investigate genetic mapping and 
genetic structure of organism’s populations. PCR is an 
excellent technique for the amplification of repeat 
region that can be examined by gel electrophoresis and 
visualized by auto-radiography or staining. Analysis 
with multi-locus satellite has been used to explore 
population structures and to identify genetic exchange 
role in Cryptosporidium [56]. Multi-locus satellite 
technique has also been utilized to investigate zoonotic 
threat from several protozoa including 
Cryptosporidium [57]. Fingerprinting method has also 
been utilized to explore differences between C. parvum 
and C. hominis. In electrophoretic band profiles, a 
similar method revealed the substantial heterogeneity in 
clinical isolates taken from sporadic diseases and 
homogeneity among clinical isolates from an outbreak. 
Based on these studies, it is now clear that these 
diagnostic tools have given useful information on 
population structure and diversity in C. hominis and C. 
parvum and similar methods are required for other 
Cryptosporidium species. 
 PCR-based sequencing and restriction 
fragment length 
Different PCR-based methods, utilizing selective pairs 
of primers for the amplification of genetic loci followed 
by sequencing or enzymatic cleavage, have been 
employed to classify and characterize the 
Cryptosporidium species genotypes [4]. Several loci (key 
markers) comprise rRNA genes and spacers, COWP 
(Cryptosporidium oocyst wall protein), HSP70 (70 kDa 
heat shock protein), TRAP (Thrombospondin-related 
adhesive protein) genes and GP60 (genes and the 60 kDa 
glycoprotein). The SSU-rRNA gene gave a valuable 
genetic marker for Cryptosporidium identification 
having great interspecific and low intraspecific sequence 
differences [7,58]. Markers allow identification at 
species level include the hsp70 and actin gene which 
have been used together with SSU (small subunit) in 
phylogenetic (systematic) analysis of Cryptosporidium, 
giving basic structure for members classification in the 
genus [59]. The ITS (internal transcribed spacers) of 
ribosomal DNA are helpful for revealing variability 
because their sequences possess great intraspecific 
variation rather than rRNA gene regions. Extremely 
variable loci may have repetitive microsatellite regions 
including gp60, ML1 (microsatellite locus 1) and ML2 
(microsatellite locus 2) have been used to explore 
population genetics of Cryptosporidium especially for 
C. parvum and C. hominis [60]. 
 PCR-RFLP (PCR-based restriction fragment 
length polymorphism) 
It has been used to classify Cryptosporidium spp. 
genetics in many researches. PCR-RFLP based 
genotypic analysis of gene fragment 18s rRNA has 
shown 82% isolates from C. hominis, while 18% from C. 
parvum in children [53]. Moreover, PCR-RFLP analysis 
for the gene (SSU rRNA) explains that native breeds of 
cattle do not transmit human Cryptosporidium in 
Nigeria (Kaduna State). In an advance study, four 
species of Cryptosporidium, C. bovis, C. andersoni, C. 
parvum and C. ryanae were explored by analyzing the 
SSU rRNA (18S) and COWP genes in polish breed 
cattle. This method does not identify all the sequence 
length variations in amplicons because endonuclease/s, 
which is utilized, identifies a limited number of variable 
sites. One of the gold standard methods remains the 
direct DNA sequencing to identify polymorphism or 
genetic variation and can be used for multi-copy 
(provided there is no sequence heterogeneity in copies) 
as well as single-copy genes. DNA sequence data can be 
employed for comparative genetic analysis and suitable 
for phylogenetic studies. But direct DNA sequencing 
have some restrictions, as small quantity of DNA from 
single oocyst of Cryptosporidium is not of practical 
approach for PCR amplification; amplicons are 
produced always from that isolate which represents 
oocysts population. If considerable polymorphism or 
heterogeneity present in that isolate as in first (ITS-1) 
and second (ITS-2), ITS regions may not be able to 
develop a precise sequence from an amplicon [61]. 
However, analysis of polymorphic amplicons can be 
done by mutation scanning methods. 
 Electrophoretic scanning 
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Some restrictions in the investigation of sequence 
variation can be minimized by high resolution 
electrophoretic methods. These methods are comprised 
of mutation scanning techniques, for instance, DGGE 
(denaturing gradient gel electrophoresis), TGGE 
(temperature gradient gel electrophoresis), SSCP (single 
strand conformation polymorphism) and hetero duplex 
analysis are being used. Particularly, SSCP is a valuable 
method that is based on the principle which states that 
electrophoretic movement of ssDNA molecule in non-
denaturing gel is dependent mainly on two things, its 
structure and size, enabling the method to verify 
mutation at a single point in 500bp amplicons [18]. 
Thus, PCR-based SSCP has exhibited a useful diagnostic 
tool for identification and genotypes of 
Cryptosporidium species to verify genetic variation 
among and within large quantity of samples. In 
Cryptosporidium, this has also been utilized for 
exhibiting sequence variation in the regions of nuclear 
gene (SSU and hsp70) with lesser number of samples 
from proper oocyst DNA. 
New drug discoveries 
Several therapeutics have been tested against 
cryptosporidiosis such as macrolide Paromomycin 
aminoglycoside, ionophores and immunotherapy. 
However, Nitazoxanide was the only anti-protozoal 
drug against cryptosporidiosis, which was approved in 
2006 by the U.S. food and drug administration. But this 
drug is only effective in immunocompetent patients. In 
immunocompromised patients, combination of 
medicine; paromomycin + protease inhibitors along 
with antiretroviral therapy is recommended [62-65]. 
The new drugs recently approved for the treatment of 
cryptosporidiosis along with their limitations have been 
mentioned in table 3.  
Conclusion 
Cryptosporidium spp. is an emerging zoonotic 
protozoan parasite which is being transmitted through 
contaminated food, raw vegetables and drinking water 
which may be a leading cause of gastrointestinal illnesses 
in humans. Cryptosporidium parvum and 
Cryptosporidium hominis are most prevalent parasites 
among all kind of hosts. These species cause chronic 
diarrhea and dysentery in young children and 
particularly, in immunocompromised patients or 
HIV/AIDS patients. Recovery chances from this 
parasitic infection are very rare in HIV patients. Even, 
no antiparasitic drug against these virulent protozoa is 
efficacious in HIV infected/ AIDS patients until a 
suitable anti-retroviral medicine is given in 
combination. Nitazoxanide is a drug of choice against 
Cryptosporidium spp. and is recently approved by FDA. 
Moreover, the most appropriate option to avoid 
cryptosporidiosis is to adopt better hygienic and 
sanitation conditions. 
Drug Status Limitations Reference 
Nitazoxanide Approved for use 
for 
cryptosporidiosis 
but not with HIV co-
infection 
Efficacy 56–96% in healthy 
hosts. 
Not effective in patients with 
advanced AIDS. 
Costly and low availability. 
[63] 
Paromomycin Approved for use 
for other indications 
Limited efficacy in patients 
with AIDS. 
No controlled data in other 
groups. 
[62] 
Azithromycin Approved for use 
for other indications 
Not effective in patients with 
advanced AIDS. 
Anecdotes of efficacy in 
combination in patients with 
AIDS. 
[62] 
Rifaximin Approved for use 
for other indications 
Anecdotes of responses in 
patients with AIDS. 
[62] 
Rifabutin Approved for use 
for other indications 
Effective at prevention of 
cryptosporidiosis in studies 
of Mycobacterium avium 
prophylaxis. 
[62] 
HIV protease 
inhibitors 
Approved for use 
for HIV treatment 
Associated with resolution of 
cryptosporidiosis in patients 
with AIDS. 
Partial efficacy against 
Cryptosporidium parvum in 
mouse models. 
[62] 
Table 3: Some chemotherapeutic drugs against cryptosporidiosis 
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